News Headline

  • Monday, June 8, 2015

     The Columbia Center for Translational Immunology is honored to welcome two esteemed colleagues to the center, Dr. David H. Sachs, MD and Dr. Kazuhiko Yamada, MD, PhD who will be joining us this summer.
    Dr. Sachs, who won the 2014...

Recent News

  • Project: The Immune Privilege of the Hematopoietic Stem Cell Niche
    Monday, January 26, 2015
     Dr. Joji Fujisaki, MD. PhD, was recently awarded a prestigious 2015 Schaefer Research Scholar Award by Columbia University, the selection for which is based upon “outstanding merit for the proposed research and as carried out in the past year; along with the likelihood of outstanding future research. See...
  • Dr. Donna Farber, et al
    Thursday, November 6, 2014
    Mechanisms for human memory T cell differentiation and maintenance have largely been inferred from studies of peripheral blood, though the majority of T cells are found in lymphoid and mucosal sites. We present here a multidimensional, quantitative analysis of human T cell compartmentalization and maintenance over six...
  • Friday, October 10, 2014
     Clinical Trials Office Pilot Award from the Irving Institute for Translational Research for a grant entitled: "Combined liver and bone marrow transplantation for the induction of tolerance to liver allografts". The goal of this study is to induce tolerance to liver allografts in a preclinical cynomolgus...
  • Thursday, May 15, 2014
    New York-Presbyterian/Columbia University Medical Center has opened the Irving Bone Marrow Transplant Unit, a state-of-the-art facility for comprehensive bone marrow transplant (BMT) care. The new unit features 18 inpatient rooms, a high-tech nurses station for individual patient monitoring, and a specialized airflow system...
  • American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
    Friday, December 13, 2013
    Avoidance of long-term immunosuppression is a desired goal in organ transplantation. Mixed chimerism offers a promising approach to tolerance induction, and we have aimed to develop low-toxicity, nonimmunodepleting approaches to achieve this outcome. In a mouse model achieving fully MHC-mismatched allogeneic bone marrow...